Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TGM2 | P21980 | 1/20 | 0.55 |
| ▸ | NT5E | P21589 | 1/20 | 0.54 |
| ▸ | FUT5 | Q11128 | 1/20 | 0.52 |
| ▸ | KRAS | P01116 | 4/20 | 0.51 |
| ▸ | HINT1 | P49773 | 3/20 | 0.51 |
| ▸ | IMPDH2 | P12268 | 3/20 | 0.50 |
| ▸ | HPGD | P15428 | 1/20 | 0.50 |
| ▸ | IMPDH1 | P20839 | 1/20 | 0.48 |
| ▸ | P2RY2 | P41231 | 1/20 | 0.48 |
| ▸ | P2RY4 | P51582 | 1/20 | 0.48 |
| ▸ | P2RY6 | Q15077 | 1/20 | 0.48 |
| ▸ | DCPS | Q96C86 | 1/20 | 0.47 |
| ▸ | GSK3A | P49840 | 2/20 | 0.47 |
| ▸ | RPS6KA3 | P51812 | 2/20 | 0.47 |
| ▸ | MAPK14 | Q16539 | 2/20 | 0.47 |
| ▸ | TAS1R3 | Q7RTX0 | 1/20 | 0.47 |
| ▸ | TAS1R1 | Q7RTX1 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Guanosine SCHEMBL8429254 | 0.93 | TGM2 (0.55) | TGM2NT5EFUT5KRASHINT1 | |
| Guanosine SCHEMBL3264840 | 0.93 | TGM2 (0.55) | TGM2NT5EFUT5KRASHINT1 | |
| Guanosine SCHEMBL4816737 | 0.93 | TGM2 (0.55) | TGM2NT5EFUT5KRASHINT1 | |
| Guanosine SCHEMBL8425223 | 0.89 | NT5E (0.58) | TGM2NT5EFUT5KRASHINT1 | |
| SCHEMBL1697432 | 0.89 | NT5E (0.61) | TGM2NT5EFUT5KRASHINT1 | |
| SCHEMBL6027526 | 0.89 | NT5E (0.61) | TGM2NT5EFUT5KRASHINT1 | |
| Guanosine SCHEMBL30589987 | 0.87 | NT5E (0.69) | TGM2NT5EFUT5KRASHINT1 | |
| Guanosine SCHEMBL9827513 | 0.87 | NT5E (0.69) | TGM2NT5EFUT5KRASHINT1 | |
| Guanosine SCHEMBL6066347 | 0.87 | NT5E (0.69) | TGM2NT5EFUT5KRASHINT1 | |
| Guanosine SCHEMBL30125158 | 0.86 | NT5E (0.68) | TGM2NT5EFUT5KRASHINT1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 299 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120020261-A | Method for total synthesis of N-glycan | 中国科学院上海药物研究所 | 2025-05-20 | — | — | CN | claimed |
| US-20250115867-A1 | AUGMENTATION OF CELL THERAPY EFFICACY INCLUDING TREATMENT WITH ALPHA, 1,3 FUCOSYLTRANSFERASE | TARGAZYME INC (US) | 2025-04-10 | — | — | US | claimed |
| US-20240418701-A1 | SINGLE MOLECULE IDENTIFICATION WITH A REACTIVE HETERO-NANOPORE | NANJING UNIVERSITY (CN) | 2024-12-19 | — | — | US | claimed |
| US-20240271093-A1 | AUGMENTATION OF CELL THERAPY EFFICACY INCLUDING TREATMENT WITH ALPHA 1,3 FUCOSYLTRANSFERASE | TARGAZYME INC (US) | 2024-08-15 | — | — | US | claimed |
| EP-4413379-A1 | SINGLE MOLECULE IDENTIFICATION WITH A REACTIVE HETERO-NANOPORE | Nanjing University (CN) | 2024-08-14 | — | — | EP | claimed |
| CN-118103711-A | Single molecule identification with reactive heterogeneous nanopores | 南京大学 | 2024-05-28 | — | — | CN | claimed |
| US-11976298-B2 | Augmentation of cell therapy efficacy including treatment with alpha 1,3 fucosyltransferase | Targazyme, Inc. (US) | 2024-05-07 | — | — | US | claimed |
| CN-117683833-A | Method for preparing nucleotide sugar from nucleoside monophosphate | 山东大学 | 2024-03-12 | — | — | CN | claimed |
| US-20230416681-A9 | Augmentation of Cell Therapy Efficacy Including Treatment with Alpha 1,3 Fucosyltransferase | TARGAZYME INC (US) | 2023-12-28 | — | — | US | claimed |
| CN-112662604-B | Recombinant escherichia coli for synthesizing 3-fucosyllactose and construction method thereof | 量子高科(广东)生物有限公司 | 2023-10-20 | — | — | CN | claimed |
| WO-2007047654-A2 | SPECIFIC ACCEPTORS FOR TRANFERASES TO SACCHARIDES AND METHOD FOR OBTAINING AND USING SAME | HEALTH RESEARCH, INC. (US) | 2007-04-26 | — | — | WO | claimed |
| EP-0816503-B1 | ALPHA-1-6 FUCOSYLTRANSFERASES | TOYO BOSEKI (JP) | 2006-07-05 | — | — | EP | claimed |
| EP-1194168-A2 | METHODS AND PRODUCTS FOR MANIPULATING UNCOUPLING PROTEIN EXPRESSION | UNIVERSITY OF VERMONT AND STATE AGRICULTURAL COLLEGE (US) | 2002-04-10 | — | — | EP | claimed |
| US-6187754-B1 | Sialyl-Lewisa and sialyl-Lewisx epitode analogues | GLYCOTECH CORP. | 2001-02-13 | — | — | US | claimed |
| WO-2000078941-A2 | METHODS AND PRODUCTS FOR MANIPULATING UNCOUPLING PROTEIN EXPRESSION | UNIVERSITY OF VERMONT AND STATE AGRICULTURAL COLLEGE (US) | 2000-12-28 | — | — | WO | claimed |
| US-5888777-A | Process for the complete removal of protective groups on nucleoside diphosphate and triphosphate sugars with acetylesterase | NOVARTIS AG (CH) | 1999-03-30 | — | — | US | claimed |
| EP-0886639-A1 | SIALYL-LEWISa AND SIALYL-LEWISx EPITOPE ANALOGUES | GlycoTech Corp. (US) | 1998-12-30 | — | — | EP | claimed |
| EP-0801684-A1 | PROCESS FOR THE COMPLETE REMOVAL OF PROTECTIVE GROUPS ON NUCLEOSIDE DIPHOSPHATE AND TRIPHOSPHATE SUGARS | Novartis AG (CH) | 1997-10-22 | — | — | EP | claimed |
| WO-1997028174-A1 | SIALYL-LEWISa AND SIALYL-LEWISx EPITOPE ANALOGUES | NOVARTIS AG (CH) | 1997-08-07 | — | — | WO | claimed |
| WO-1996024683-A1 | PROCESS FOR THE COMPLETE REMOVAL OF PROTECTIVE GROUPS ON NUCLEOSIDE DIPHOSPHATE AND TRIPHOSPHATE SUGARS | NOVARTIS AG (CH) | 1996-08-15 | — | — | WO | claimed |